DuBois Barent, Louey Samantha, Giraud George D, Cherala Ganesh, Jonker Sonnet S
Department of Pharmacy Practice, College of Pharmacy, Oregon State University, Corvallis, OR, USA.
Oregon Health & Science University, Portland, OR, USA.
Basic Clin Pharmacol Toxicol. 2015 Oct;117(4):226-33. doi: 10.1111/bcpt.12395. Epub 2015 Mar 19.
Understanding theophylline pharmacokinetics (PK) in the foetus is essential to prevent in utero toxicity and optimize prophylactic therapies. Previous studies in pregnancy have been obfuscated by maternal dosing and inadequate sampling in the foetus; both render modelling of foetal PK difficult. Six ewes carrying singleton foetuses received theophylline (60 mg) into the foetal jugular vein. Blood samples were drawn from the foetus and ewe over 36 hr. Serum concentrations were measured. Maternal and foetal pharmacokinetic parameters were estimated. Foetal non-compartmental pharmacokinetic parameters were as follows: half-life 7.37 ± 1.22 hr; volume of distribution 44.62 ± 11.45 L; area under the curve 14.82 ± 2.71 hr/(μg/mL); and clearance 4.15 ± 0.70 L/hr. Rapid theophylline distribution across the placenta was observed. Maternal non-compartmental pharmacokinetic parameters were as follows: half-life 6.54 ± 2.44 hr; volume of distribution 32.48 ± 9.99 L; area under the curve 16.28 ± 4.53 hr/(μg/mL); and clearance 3.69 ± 1.47 L/hr. Foetal and ewe serum concentration-time profiles were fit together into a 3-compartment population pharmacokinetic model, and parameters were as follows: central volume 1.38 ± 0.11 L; 2nd peripheral compartment volume 3.11 ± 0.29 L; 3rd peripheral compartment volume 60.14 ± 6.02 L; elimination clearance 9.89 ± 0.90 L/hr; distribution clearance between central and 2nd compartment 30.87 ± 2.31 L/hr; and distribution clearance between 2nd and 3rd compartments 13.89 ± 1.11 L/hr. Cytochrome P4501A expression was robust in maternal liver; negligible activities were observed in placenta, foetal liver and foetal kidney. In vitro protein binding of theophylline was 30% lower in foetal serum compared to maternal serum (29.7 ± 4.4 versus 42.0 ± 3.6%-bound). Free concentrations were lower in the foetus than in the ewe, suggesting active transport across placenta. In summary, foetal clearance of theophylline is attributable to rapid distribution into the maternal circulation across the placenta followed by greater maternal protein binding and metabolic activity.
了解胎儿体内茶碱的药代动力学(PK)对于预防子宫内毒性和优化预防性治疗至关重要。先前关于孕期的研究因母体给药和胎儿采样不足而受到干扰;这两者都使得胎儿PK建模变得困难。六只怀有单胎胎儿的母羊经胎儿颈静脉接受了60毫克茶碱。在36小时内从胎儿和母羊身上采集血样。测量血清浓度。估算母体和胎儿的药代动力学参数。胎儿的非房室药代动力学参数如下:半衰期7.37±1.22小时;分布容积44.62±11.45升;曲线下面积14.82±2.71小时/(微克/毫升);清除率4.15±0.70升/小时。观察到茶碱在胎盘内快速分布。母体的非房室药代动力学参数如下:半衰期6.54±2.44小时;分布容积32.48±9.99升;曲线下面积16.28±4.53小时/(微克/毫升);清除率3.69±1.47升/小时。将胎儿和母羊的血清浓度-时间曲线拟合到一个三室群体药代动力学模型中,参数如下:中央室容积l.38±0.11升;第二外周室容积3.11±0.29升;第三外周室容积60.14±6.02升;消除清除率9.89±0.90升/小时;中央室与第二室之间的分布清除率30.87±2.31升/小时;第二室与第三室之间的分布清除率13.89±1.11升/小时。细胞色素P4501A在母体肝脏中表达强烈;在胎盘、胎儿肝脏和胎儿肾脏中观察到的活性可忽略不计。与母体血清相比,茶碱在胎儿血清中的体外蛋白结合率低30%(结合率分别为29.7±4.4%和42.0±3.6%)。胎儿体内的游离浓度低于母羊,表明存在跨胎盘的主动转运。总之,胎儿对茶碱的清除归因于其通过胎盘快速分布到母体循环中,随后母体蛋白结合和代谢活性增强。